Role of antibody in Coxiella burnetii infection - PubMed (original) (raw)
Role of antibody in Coxiella burnetii infection
R C Humphres et al. Infect Immun. 1981 Feb.
Abstract
BALB/c mice infected with Coxiella burnetii phase I developed a state of acquired resistance which could be detected during week 2 postinfection. Immune serum, administered to normal mice 24 h before challenge with C. burnetii, appeared to accelerate the development of resistance. An increased clearance rate could be measured in these serum recipients 1 week postinfection. Simultaneous administration of immune serum and C. burnetii did not affect the normal clearance rate of rickettsiae from the spleens of infected mice during week 1, but enhanced clearance of the organism by 14 days postchallenge. Passive transfer of immune serum 24 h after challenge of normal mice with viable C. burnetii had no effect on rickettsial growth within the spleens of animals treated in this fashion. Treatment of athymic mice with immune serum 24 h before challenge with C. burnetii had no effect on rickettsial multiplication within the spleens of these T-cell-deficient animals.
Similar articles
- Humoral immune response to Q fever: enzyme-linked immunosorbent assay antibody response to Coxiella burnetii in experimentally infected guinea pigs.
Williams JC, Thomas LA, Peacock MG. Williams JC, et al. J Clin Microbiol. 1986 Dec;24(6):935-9. doi: 10.1128/jcm.24.6.935-939.1986. J Clin Microbiol. 1986. PMID: 3537005 Free PMC article. - Experimental Q fever infection in congenitally athymic nude mice.
Kishimoto RA, Rozmiarek H, Larson EW. Kishimoto RA, et al. Infect Immun. 1978 Oct;22(1):69-71. doi: 10.1128/iai.22.1.69-71.1978. Infect Immun. 1978. PMID: 730352 Free PMC article. - Search for correlates of resistance to virulent challenge in mice immunized with Coxiella burnetii.
Kazár J, El-Najdawi E, Brezina R, Schramek S. Kazár J, et al. Acta Virol. 1977 Sep;21(5):422-30. Acta Virol. 1977. PMID: 22238 - Q fever: persistence of antigenic non-viable cell residues of Coxiella burnetii in the host--implications for post Q fever infection fatigue syndrome and other chronic sequelae.
Marmion BP, Sukocheva O, Storm PA, Lockhart M, Turra M, Kok T, Ayres J, Routledge H, Graves S. Marmion BP, et al. QJM. 2009 Oct;102(10):673-84. doi: 10.1093/qjmed/hcp077. Epub 2009 Jun 25. QJM. 2009. PMID: 19556396 Review. - Immunity in Q fever.
Kazár J. Kazár J. Acta Virol. 1988 Jul;32(4):358-68. Acta Virol. 1988. PMID: 2903642 Review.
Cited by
- Vaccine development: obligate intracellular bacteria new tools, old pathogens: the current state of vaccines against obligate intracellular bacteria.
van Schaik EJ, Fratzke AP, Gregory AE, Dumaine JE, Samuel JE. van Schaik EJ, et al. Front Cell Infect Microbiol. 2024 Mar 19;14:1282183. doi: 10.3389/fcimb.2024.1282183. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38567021 Free PMC article. Review. - Cytometry profiling of ex vivo recall responses to Coxiella burnetii in previously naturally exposed individuals reveals long-term changes in both adaptive and innate immune cellular compartments.
Raju Paul S, Scholzen A, Reeves PM, Shepard R, Hess JM, Dzeng RK, Korek S, Garritsen A, Poznansky MC, Sluder AE. Raju Paul S, et al. Front Immunol. 2023 Oct 11;14:1249581. doi: 10.3389/fimmu.2023.1249581. eCollection 2023. Front Immunol. 2023. PMID: 37885896 Free PMC article. - Natural Exposure- and Vaccination-Induced Profiles of Ex Vivo Whole Blood Cytokine Responses to Coxiella burnetii.
Raju Paul S, Scholzen A, Mukhtar G, Wilkinson S, Hobson P, Dzeng RK, Evans J, Robson J, Cobbold R, Graves S, Poznansky MC, Garritsen A, Sluder AE. Raju Paul S, et al. Front Immunol. 2022 Jun 23;13:886698. doi: 10.3389/fimmu.2022.886698. eCollection 2022. Front Immunol. 2022. PMID: 35812430 Free PMC article. - Immunogenicity and Reactogenicity in Q Fever Vaccine Development.
Fratzke AP, van Schaik EJ, Samuel JE. Fratzke AP, et al. Front Immunol. 2022 May 26;13:886810. doi: 10.3389/fimmu.2022.886810. eCollection 2022. Front Immunol. 2022. PMID: 35693783 Free PMC article. Review. - Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of Coxiella burnetii Immunity.
Sluder AE, Raju Paul S, Moise L, Dold C, Richard G, Silva-Reyes L, Baeten LA, Scholzen A, Reeves PM, Pollard AJ, Garritsen A, Bowen RA, De Groot AS, Rollier C, Poznansky MC. Sluder AE, et al. Front Immunol. 2022 May 16;13:901372. doi: 10.3389/fimmu.2022.901372. eCollection 2022. Front Immunol. 2022. PMID: 35651616 Free PMC article.
References
- Health Lab Sci. 1967 Oct;4(4):236-44 - PubMed
- Zentralbl Bakteriol Orig. 1968 Apr;206(3):321-9 - PubMed
- Infect Immun. 1975 Feb;11(2):280-6 - PubMed
- Acta Virol. 1975 Sep;19(5):426-31 - PubMed
- J Immunol. 1976 Sep;117(3):996-1003 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources